Newsroom | 5033 results

Sorted by: Latest

Optical
-

betterview franchit le cap des 20 000 yeux traités en quatre ans

WINTERTHUR, Suisse--(BUSINESS WIRE)--betterview, un fournisseur suisse de chirurgie réfractive, a annoncé qu'il avait atteint le cap des 20 000 yeux traités depuis sa création en 2021. Depuis son lancement, l'entreprise a construit un réseau de dix cliniques et son propre centre chirurgical, couvrant toutes les régions linguistiques de la Suisse. Cette expansion constante a permis à betterview de se positionner comme l'un des principaux fournisseurs de correction de la vue au laser du pays. bet...
-

National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships

DULUTH, Ga.--(BUSINESS WIRE)--National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, has awarded $7,000 in scholarships to three optometry students whose passion for community impact and commitment to vision equity stood out among this year’s applicants for the National Optometric Student Association (NOSA) scholarship program. This year’s prompt challenged students to explore the link between vision health and success in school...
-

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free redness reliever eye drops compared to LUMIFY redness reliever eye drops for reducing ocular redness. “Since launching in 2018, LUMIFY has been the No. 1 doctor-recommended redn...
-

Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease

CAMBRIDGE, England--(BUSINESS WIRE)--Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical trial for its lead candidate EXN407. The CLEAR-DE (Clinical Evaluation of a New Eye Drop for Alleviating Retinopathy in Diabetic Eye Disease) trial will further evaluate the clinical efficacy, optimal dosing and safety profile of EXN407 in patients with non-prolif...
-

betterview verzeichnet 20'000 behandelte Augen in vier Jahren

WINTERTHUR, Schweiz--(BUSINESS WIRE)--betterview, ein Anbieter für refraktive Chirurgie in der Schweiz, gibt bekannt, dass das Unternehmen die Marke von 20'000 behandelten Augen erreicht hat. Der Meilenstein wurde seit der Gründung des Unternehmens im Jahr 2021 erzielt. Das Unternehmen hat seither ein Netzwerk mit zehn Shops und einem eigenen Operationscenter aufgebaut, das alle Sprachregionen der Schweiz abdeckt. Die kontinuierliche Expansion macht betterview zu einem der grösseren Anbieter fü...
-

betterview Reaches 20,000 Eyes Treated in Four Years

WINTERTHUR, Switzerland--(BUSINESS WIRE)--betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of ten clinics and its own surgical center, covering all language regions of Switzerland. This continued expansion has positioned betterview as one of the country’s leading providers of laser vision correction. betterview offers a range of refractive s...
-

Eye Spear Analysis Report 2025-2032 | Company Profiles, Product Details, Pictures, Recent Developments and Key Market Dynamics - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Eye Spear Market (By Product Type, Segment, Application, End-User, Sales Channel, Regional Analysis), Company Profiles, Eye Spear Product Details, Pictures, Recent Developments and Market Dynamics - Global Forecast (2025 - 2032)" report has been added to ResearchAndMarkets.com's offering. The global eye spear market is projected to reach US$ 265.6 Million by 2032, from US$ 162.7 Million in 2024. The application of eye spears extends across a range of surgical setti...
-

National Vision Holdings, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the “Investors” section of the Company’s website at https://ir.nationalvision.com/. A live audio webcast of the conference...
-

Affirm and New Look Vision Group partner to offer flexible payment options across leading eyewear retailers in Canada

TORONTO--(BUSINESS WIRE)--Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, and New Look Vision Group, a leading North American optical retailer with over 475 stores in the US and Canada, today announced a new partnership in Canada, bringing Affirm’s honest, transparent pay-over-time options to customers shopping at New Look Eyewear, Greiche & Scaff, Vogue Optical, IRIS, and more. Whether shopping for prescription glasses, sunglasses, or co...
-

Affirm et Groupe Vision New Look s’associent pour offrir des options de paiement flexibles dans les principales lunetteries au Canada

TORONTO--(BUSINESS WIRE)--Affirm (NASDAQ : AFRM), le réseau de paiement qui aide les consommateurs à acheter ce qu’ils souhaitenten toute liberté et soutient la croissance des marchands, et Groupe Vision New Look, un chef de file nord-américain des magasins de détail d’optique avec plus de 475 magasins au Canada et aux États-Unis, ont annoncé aujourd’hui un nouveau partenariat au Canada. Ce partenariat permettra aux clients de Lunetterie New Look, Greiche & Scaff, Vogue Optical, IRIS et d’a...